Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Interest Expenses (2021 - 2026)

HeartSciences filings provide 6 years of Interest Expenses readings, the most recent being $61509.0 for Q1 2026.

  • On a quarterly basis, Interest Expenses fell 65.73% to $61509.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $705583.0, a 107.2% increase, with the full-year FY2025 number at $500453.0, up 41.34% from a year prior.
  • Interest Expenses hit $61509.0 in Q1 2026 for HeartSciences, down from $279534.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $279534.0 in Q4 2025 to a low of $7.0 in Q1 2023.
  • Median Interest Expenses over the past 5 years was $117598.0 (2024), compared with a mean of $106220.0.
  • Biggest five-year swings in Interest Expenses: plummeted 99.99% in 2023 and later soared 1691971.43% in 2024.
  • HeartSciences' Interest Expenses stood at $32805.0 in 2022, then soared by 443.94% to $178438.0 in 2023, then plummeted by 34.1% to $117598.0 in 2024, then skyrocketed by 137.7% to $279534.0 in 2025, then tumbled by 78.0% to $61509.0 in 2026.
  • The last three reported values for Interest Expenses were $61509.0 (Q1 2026), $279534.0 (Q4 2025), and $183688.0 (Q3 2025) per Business Quant data.